|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00484107 |
|
Date of registration:
|
07/06/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women
|
|
Scientific title:
|
A Postmarketing Surveillance Study Evaluating the Tolerability and Safety of PREMARIN VAGINAL CREAM in Indian Postmenopausal Women |
|
Date of first enrolment:
|
September 2005 |
|
Target sample size:
|
200 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00484107 |
|
Study type:
|
Observational |
|
Study design:
|
N/A
|
|
|
Contacts
|
|
Name:
|
Medical Monitor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Wyeth is now a wholly owned subsidiary of Pfizer |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients in whom Premarin vaginal cream is indicated.
- In the opinion of the investigator, sufficient intelligence and motivation for the
patient to continue throughout the study.
- Provide signed informed consent.
Exclusion Criteria:
- Patients not willing to give informed consent.
Age minimum:
40 Years
Age maximum:
65 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Postmenopause
|
|
Intervention(s)
|
|
Drug: Conjugated Estrogen Cream (Premarin®)
|
|
Secondary ID(s)
|
|
0713V-101833
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|